American Vanguard Corp

AVD remains in an early Stage 1 consolidation after a steep decline, with intermediate resistance forming at flattening EMAs and a declining 200 DMA. Medium-term bias stays bearish on the lower-high structure, while short-term timing is neutral. Defer selling into the $2.90–3.00 zone on rejections at the 9/20 EMA or 50 SMA. A decisive break below the EMA zone would trigger accelerated bearish risk and invalidate the current setup.

• ↑Net sales $124M (+7% YoY), domestic crop sales up 17%.
• ↑Adjusted EBITDA rose 245% YoY to $10.3M, driven by cost control and margin mix.
• ↓Total debt increased to $267M from $166M, straining financial flexibility.